MetLife, Inc. (NYSE:MET – Get Free Report) has received a consensus rating of “Moderate Buy” from the thirteen ratings firms that are currently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. The average 1-year target price among brokerages that have covered the stock in the last year is $84.54.
MET has been the topic of several research reports. Morgan Stanley dropped their price objective on shares of MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a report on Monday, August 19th. Jefferies Financial Group upped their price target on MetLife from $83.00 to $86.00 and gave the stock a “buy” rating in a research note on Thursday, July 18th. Bank of America reduced their price objective on MetLife from $99.00 to $96.00 and set a “buy” rating for the company in a research note on Thursday, August 1st. StockNews.com downgraded MetLife from a “buy” rating to a “hold” rating in a report on Tuesday, September 10th. Finally, Citigroup increased their target price on MetLife from $83.00 to $89.00 and gave the stock a “buy” rating in a report on Tuesday, July 23rd.
View Our Latest Report on MetLife
Institutional Trading of MetLife
MetLife Stock Down 1.2 %
Shares of MetLife stock opened at $80.45 on Wednesday. The stock’s 50-day moving average is $74.90 and its 200 day moving average is $72.78. MetLife has a one year low of $57.91 and a one year high of $81.85. The firm has a market cap of $57.21 billion, a price-to-earnings ratio of 27.65, a PEG ratio of 0.61 and a beta of 1.04. The company has a debt-to-equity ratio of 0.56, a current ratio of 0.16 and a quick ratio of 0.16.
MetLife (NYSE:MET – Get Free Report) last released its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $2.28 earnings per share for the quarter, beating the consensus estimate of $2.13 by $0.15. The company had revenue of $17.82 billion during the quarter, compared to analyst estimates of $18.57 billion. MetLife had a net margin of 4.23% and a return on equity of 21.41%. MetLife’s revenue for the quarter was up 7.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.94 EPS. Equities research analysts anticipate that MetLife will post 8.67 EPS for the current year.
MetLife Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 10th. Stockholders of record on Tuesday, August 6th were paid a $0.545 dividend. The ex-dividend date of this dividend was Tuesday, August 6th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.71%. MetLife’s payout ratio is presently 74.91%.
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
- Five stocks we like better than MetLife
- Where to Find Earnings Call Transcripts
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- 3 Healthcare Dividend Stocks to Buy
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- What is Insider Trading? What You Can Learn from Insider Trading
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.